Avants, B. B., Tustison, N., & Song, G. (2009). Advanced Normalization Tools: The Insight Journal, V1.0.
Backes, M., Genç, B., Schreck, J., Doerfler, W., Lehmkuhl, G., & von Gontard, A. (2000). Cognitive and behavioral profile of fragile X boys: Correlations to molecular data. American Journal of Medical Genetics, 95(2), 150–156.
Bailey, D. B., Hatton, D. D., Skinner, M., & Mesibov, G. (2001). Autistic Behavior, FMR1 Protein, and Developmental Trajectories in Young Males with Fragile X Syndrome. Journal of Autism and Developmental Disorders, 31(2), 165–174. https://doi.org/10.1023/A:1010747131386
Berry-Kravis, E., Knox, A., & Hervey, C. (2011). Targeted treatments for fragile X syndrome. Journal of Neurodevelopmental Disorders, 3(3), 193. https://doi.org/10.1007/s11689-011-9074-7
Berry-Kravis, E., & Potanos, K. (2004). Psychopharmacology in fragile X syndrome—Present and future. Mental Retardation and Developmental Disabilities Research Reviews, 10(1), 42–48. https://doi.org/10.1002/mrdd.20007
Brašić, J. R., Nandi, A., Russell, D. S., Jennings, D., Barret, O., Mathur, A., Slifer, K., Sedlak, T., Martin, S. D., Brinson, Z., Vyas, P., Seibyl, J. P., Berry-Kravis, E. M., Wong, D. F., & Budimirovic, D. B. (2020). Reduced Expression of Cerebral Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome. Brain Sciences, 10(12), 899. https://doi.org/10.3390/brainsci10120899
Gu, M., Hurd, R., Noeske, R., Baltusis, L., Hancock, R., Sacchet, M. D., Gotlib, I. H., Chin, F. T., & Spielman, D. M. (2018). GABA editing with macromolecule suppression using an improved MEGA-SPECIAL sequence. Magnetic Resonance in Medicine, 79(1), 41–47. https://doi.org/10.1002/mrm.26691
Gousias, I. S., Rueckert, D., Heckemann, R. A., Dyet, L. E., Boardman, J. P., Edwards, A. D., & Hammers, A. (2008). Automatic segmentation of brain MRIs of 2-year-olds into 83 regions of interest. NeuroImage, 40(2), 672-684. doi:10.1016/j.neuroimage.2007.11.034
Hammers, A., Allom, R., Koepp, M. J., Free, S. L., Myers, R., Lemieux, L., Mitchell, T. N., Brooks, D. J., & Duncan, J. S. (2003). Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Human Brain Mapping, 19(4), 224–247. https://doi.org/10.1002/hbm.10123
Hunter, J., Rivero‐Arias, O., Angelov, A., Kim, E., Fotheringham, I., & Leal, J. (2014). Epidemiology of fragile X syndrome: A systematic review and meta-analysis. American Journal of Medical Genetics Part A, 164(7), 1648–1658. https://doi.org/10.1002/ajmg.a.36511
Ichise, M., & Ballinger, J. R. (1996). Editorial: SPECT imaging of dopamine receptors. J Nucl Med, 37, 1591-1595.
Laxman, D. J., Greenberg, J. S., DaWalt, L. S., Hong, J., Aman, M. G., & Mailick, M. (2018). Medication use by adolescents and adults with fragile X syndrome. Journal of Intellectual Disability Research, 62(2), 94–105. https://doi.org/10.1111/jir.12433
Palner, M., Beinat, C., Banister, S., Zanderigo, F., Park, J. H., Shen, B., Hjoernevik, T., Jung, J. H., Lee, B. C., Kim, S. E., Fung, L., & Chin, F. T. (2016). Effects of common anesthetic agents on [18F]flumazenil binding to the GABAA receptor. EJNMMI Research, 6(1), 80. https://doi.org/10.1186/s13550-016-0235-2
Smith, S. M., Jenkinson, M., Johansen-Berg, H., Rueckert, D., Nichols, T. E., Mackay, C. E., . . .
Behrens, T. E. (2006). Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data. NeuroImage, 31(4), 1487-1505. doi:10.1016/j.neuroimage.2006.02.024
Smith, S. M., Jenkinson, M., Woolrich, M. W., Beckmann, C. F., Behrens, T. E., Johansen-Berg, H., . . . Matthews, P. M. (2004). Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage, 23. doi:10.1016/j.neuroimage.2004.07.051
Tassone, F., Iong, K. P., Tong, T.-H., Lo, J., Gane, L. W., Berry-Kravis, E., Nguyen, D., Mu, L. Y., Laffin, J., Bailey, D. B., & Hagerman, R. J. (2012). FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States. Genome Medicine, 4(12), 100. https://doi.org/10.1186/gm401
The National Institue of Mental Health. (2020, August 17). Fragile X syndrome. Genetics Home Reference. https://ghr.nlm.nih.gov/condition/fragile-x-syndrome
Thurman, A. J., McDuffie, A., Kover, S. T., Hagerman, R. J., & Abbeduto, L. (2015). Autism Symptomatology in Boys with Fragile X Syndrome: A Cross Sectional Developmental Trajectories Comparison with Nonsyndromic Autism Spectrum Disorder. Journal of Autism and Developmental Disorders, 45(9), 2816–2832. https://doi.org/10.1007/s10803-015-2443-4
Verkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., Eussen, B. E., van Ommen, G.-J. B., Blonden, L. A. J., Riggins, G. J., Chastain, J. L., Kunst, C. B., Galjaard, H., Thomas Caskey, C., Nelson, D. L., … Warren, S. T. (1991). Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell, 65(5), 905–914. https://doi.org/10.1016/0092-8674(91)90397-H